Organigram Global Inc 6-K, filed Jan 16, 2020
Organigram Global Inc. (OGI)
6-K
2020-01-16
For: 2020-01-16
View Original
Added on
April 11, 2026
About this 6-K
Organigram Global Inc filed this 6-K on January 16, 2020.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2020
Commission File No. 001-38885
ORGANIGRAM HOLDINGS INC.
(Translation of registrant's name into English)
(Translation of registrant's name into English)
35 English Drive
Moncton, New Brunswick, Canada E1E 3X3
Moncton, New Brunswick, Canada E1E 3X3
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40‑F
Form 20-F [ ] Form 40-F [X]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]
SUBMITTED HEREWITH
|
Exhibits
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ORGANIGRAM HOLDINGS INC.
“Paolo De Luca”
______________________________________
Paolo De Luca
Chief Financial Officer
Date: January 16, 2020
Exhibit 99.1
Organigram secures Supply Agreement with Medical Cannabis by Shoppers
Agreement highlights Company’s strong commitment to Canada’s medical cannabis community
MONCTON, New Brunswick--(BUSINESS WIRE)--January 16, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of
Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc.
(“Shoppers”).
This agreement reflects the companies’ shared commitment to offering Canadian consumers access to high quality medical cannabis products.
“We are extremely proud to partner with Shoppers and believe that our complementary approach to the medical cannabis market will offer
the full strength of our combined national networks to Canadian patients,” says Tim Emberg, Senior Vice President of Sales and Commercial Operations. “We are pleased that we will now be able to offer medical cannabis patients across the country
even greater access to our growing portfolio of high-quality products.”
Under the terms of the agreement, Organigram will provide Shoppers with a wide range of products including dried flower, oils and other
future derivative products as they become available. The agreement is for a three-year term subject to renewal for an additional two years.
“Since our inception, patients have been an important priority for our team,” says Greg Engel, CEO, Organigram. “We want patients to feel
supported and to know that we are working on developing products, technology and partnerships with their best interests in mind.”
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed
producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well
as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and
Trailblazer. Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
This news release contains forward-looking information.
Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events,
or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements
of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved
with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information including risks as disclosed in the Company’s
most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue
reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news
release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
Contacts
For Investor Relations enquiries, please contact:
Amy Schwalm
Vice President, Investor Relations
Amy.Schwalm@organigram.ca
(416) 704-9057
Vice President, Investor Relations
Amy.Schwalm@organigram.ca
(416) 704-9057
or
For Media enquiries, please contact:
Ray Gracewood
Senior Vice President, Marketing and Communications
ray.gracewood@organigram.ca
(506) 645-1653
Senior Vice President, Marketing and Communications
ray.gracewood@organigram.ca
(506) 645-1653